Smit Medimed Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 3.50 M
as on 17-07-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.59 Cr
as on 17-07-2024
- Revenue 40.89%
(FY 2023)
- Profit 164.79%
(FY 2023)
- Ebitda 86.66%
(FY 2023)
- Net Worth 47.26%
(FY 2023)
- Total Assets 17.29%
(FY 2023)
About Smit Medimed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹23.59 Cr.
Smit Bhalodia, Vinodbhai Bhalodia, Kanjibhai Bhalodia, and One other member serve as directors at the Company.
- CIN/LLPIN
U33119GJ2000PTC037394
- Company No.
037394
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2000
- Date of AGM
08 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Smit Medimed Private Limited offer?
Smit Medimed Private Limited offers a wide range of products and services, including Orthopedic Trauma Implants, Locking Plates, Bone Screws, Orthopedic Implants Plates, Orthopedic Instruments, Cancellous Screws, Orthopedic Implants, Spinal Implants, Orthopedic Locking Plates, Dynamic Compression Plate.
Who are the key members and board of directors at Smit Medimed?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanjibhai Bhalodia  | Director | 21-Feb-2000 | Current |
| Smit Bhalodia | Director | 30-Sep-2022 | Current |
| Vinodbhai Bhalodia | Director | 21-Feb-2000 | Current |
| Jaysukhbhai Bhalodia | Director | 21-Feb-2000 | Current |
Financial Performance of Smit Medimed.
Smit Medimed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.89% increase. The company also saw a substantial improvement in profitability, with a 164.79% increase in profit. The company's net worth Soared by an impressive increase of 47.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smit Medimed?
In 2023, Smit Medimed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 26 Oct 2023 | ₹2.39 Cr | Open |
Others Creation Date: 28 Jun 2023 | ₹5.00 M | Open |
Sidbi Creation Date: 18 Feb 2022 | ₹1.08 Cr | Open |
How Many Employees Work at Smit Medimed?
Smit Medimed has a workforce of 46 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smit Medimed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smit Medimed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
